Responses to Interferon of LM Cells Growing Continuously in the Absence of Serum and Exogenous Lipids

References

1. Apostolov K., Barker W. 1981; The effects of interferon on the fatty acids in uninfected cells. FEBS Letters 126:261–264
   [Google Scholar]
2. Barnes D., Sato G. 1980; Serum-free cell culture: a unifying approach. Cell 22:649–655
   [Google Scholar]
3. Brune K., Rainsford K. D., Wagner K., Peskar B. A. 1981; Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Archives of Pharmacology 315:269–278
   [Google Scholar]
4. Chandrabose K., Cuatrecasas P., Pottathil R. 1981a; Changes in fatty acyl chains of phospholipids induced by interferon in mouse sarcoma S-180 cells. Biochemical and Biophysical Research Communications 98:661–668
   [Google Scholar]
5. Chandrabose K. A., Cuatrecasas P., Pottathil R., Lang D. J. 1981b; Interferon resistant cell line lacks fatty acid cyclooxygenase activity. Science 212:329–331
   [Google Scholar]
6. Cooper J. A., Morser J., Colby M. S., Burke D. C. 1979; The toxic effect of double-stranded RNA for interferon-treated cells: evidence for a heterogeneous cellular response and the role of the cell nucleus. Journal of General Virology 43:553–561
   [Google Scholar]
7. Doi O., Doi F., Schroeder F., Alberts A. W., Vagelos P. R. 1978; Manipulation of fatty acid composition of membrane phospholipids and its effects on cell growth in mouse LM cells. Biochimica et biophysica acta 509:239–250
   [Google Scholar]
8. Emeny J. M., Morgan M. J. 1979; Susceptibility of various cells treated with interferon to the toxic effect of poly(rl). poly(rC) treatment. Journal of General Virology 43:253–255
   [Google Scholar]
9. Ferguson K. A., Glaser M., Bayer W. H., Vagelos P. R. 1975; Alteration of fatty acid composition of LM cells by lipid supplementation and temperature. Biochemistry 14:146–151
   [Google Scholar]
10. Flower R. J., Vane J. R. 1974; Some pharmacologic and biochemical aspects of prostaglandin biosynthesis and its inhibition. In Prostaglandin Synthetase Inhibitors pp 9–18 Edited by Robinson H. J., Vane J. R. New York: Raven Press;
    [Google Scholar]
11. Folch J., Lees M., Sloane Stanley G. H. 1957; A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 226:497–509
    [Google Scholar]
12. Gresser I. 1977; On the varied biologic effects of interferon. Cellular Immunology 34:406–415
    [Google Scholar]
13. Gresser I., Brouty-boye D., Thomas M. T., Macieira-coelho A. 1970; Interferon and cell division. II. Influence of various experimental conditions on the inhibition of L1210 cell multiplication in vitro by interferon preparation. Journal of the National Cancer Institute 45:1145–1153
    [Google Scholar]
14. Gresser I., Tovey M. G., Bandu M. T., Maury C., Brouty-boye D. 1976; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. Journal of Experimental Medicine 144:1305–1315
    [Google Scholar]
15. Jeffcoat R. 1979; The biosynthesis of unsaturated fatty acids and its control in mammalian liver. Essays in Biochemistry 15:1–77
    [Google Scholar]
16. Kading V. H., Blalock J. E., Gifford G. E. 1978; Effect of serum on the antiviral and anticellular activities of mouse interferon. Archives of Virology 56:237–242
    [Google Scholar]
17. Lee S. H. S., Rozee K. R. 1975; Enhanced responsiveness of L929 cells treated with interferon to arginine starvation. Experimental Cell Research 93:143–151
    [Google Scholar]
18. Lengyel P. 1981; Mechanisms of interferon action: the (2′–5′)(A)_n synthetase-RNase L pathway. In Interferon 1981: pp 77–79 Edited by Gresser I. New York: Academic Press;
    [Google Scholar]
19. Lin S. L., Ts’O P. O. P., Hollenberg M. D. 1980; The effects of interferon on epidermal growth factor action. Biochemical and Biophysical Research Communications 96:168–174
    [Google Scholar]
20. Maeda M., Doi O., Akamatsu Y. 1980; Behavior of vesicular stomatitis virus glycoprotein in mouse LM cells with modified membrane-phospholipids. Biochimica et biophysica acta 597:552–563
    [Google Scholar]
21. Oleszak E., Inglot A. D. 1980; Platelet-derived growth factor (PDGF) inhibits antiviral and anticellular action of interferon in synchronized mouse or human cells. Journal of Interferon Research 1:37–48
    [Google Scholar]
22. Pfeffer L. M., Wang E., Tamm I. 1980; Interferon effects on microfilament organization, cellular fibronectin distribution and cell motility in human fibroblasts. Journal of Cell Biology 85:9–17
    [Google Scholar]
23. Pottathil R., Chandrabose K. A., Cuatrecasas P., Lang D. J. 1980; Establishment of the interferon mediated antiviral state: role of fatty acid cyclooxygenase. Proceedings of the National Academy of Sciences of the United States of America 77:5437–5440
    [Google Scholar]
24. Saito Y., Chou S. M., Silbert D. F. 1977; Animal cell mutants defective in sterol metabolism; a specific selection procedure and partial characterization of defects. Proceedings of the National Academy of Sciences of the United States of America 74:3730–3734
    [Google Scholar]
25. Sayama S., Yoshida R., Oku T., Immanishi J., Kishida T., Hayaishi O. 1981; Inhibition of interferon mediated induction of indoleamine-2, 3-dioxygenase in mouse lung by inhibitors of prostaglandin synthesis. Proceedings of the National Academy of Sciences of the United States of America 78:7327–7330
    [Google Scholar]
26. Schroeder F., Vagelos P. R. 1976; Effects of phospholipid base analogues on the subcellular membrane ether composition of suspension cultured LM cells. Biochimica et biophysica acta 441:239–254
    [Google Scholar]
27. Stewart W. E. II 1979 The Interferon System Wien & New York: Springer-Verlag;
    [Google Scholar]
28. Stewart W. E., De clercq E., Billiau A., Desmyter I., De somer P. 1972; Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic. polyribocytidilic acid. Proceedings of the National Academy of Sciences of the United States of America 69:1851–1854
    [Google Scholar]
29. Taylor-papadimitriou J. 1980; Effects of interferons on cell growth and function. In Interferon 2: pp 13–46 Edited by Gresser I. New York: Academic Press;
    [Google Scholar]
30. Taylor-papadimitriou J., Shearer M., Rozengurt E. 1981; Inhibitory effect of interferon on cellular DNA synthesis:modulation by pure mitogenic factors. Journal of Interferon Research 1:401–409
    [Google Scholar]
31. Tovey M. G., Brouty-boye D. 1979; The use of the chemostat to study the relationship between cell growth rate, viability and the effect of interferon on L1210 cells. Experimental Cell Reasearch 118:383–388
    [Google Scholar]
32. Wallach D., Revel M. 1979; Hormonal protection of interferon-treated cells against double-stranded RNA-induced cytolysis. FEBS Letters 101:364–368
    [Google Scholar]